Clinical Outcomes After Transcatheter Aortic Valve Replacement in Patients With Concomitant Mitral Regurgitation
Authors:
- Nicolas Nunez–OrdonezNNNicolas Nunez–Ordonez
- Maria Jose RozoMRMaria Jose Rozo
- Jaime CabralesJCJaime Cabrales
- Dario EcheverriDEDario Echeverri
- Carlos Villa-HincapieCVCarlos Villa-Hincapie
- Tomas ChalelaTCTomas Chalela
- Carlos ObandoCOCarlos Obando
- Lina RamirezLRLina Ramirez
- Juan Andres SarmientoJSJuan Andres Sarmiento
- Jose Vicente Alvarez-MartinezJAJose Vicente Alvarez-Martinez
- Nestor SandovalNSNestor Sandoval
- Jaime Camacho-MackenzieJCJaime Camacho-Mackenzie
Open Access
- 21 January 2026
- journal article
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 2026 (1)
Abstract
Objectives: To describe the clinical outcomes of patients with severe aortic valve stenosis (AS) and concomitant mitral regurgitation (MR) undergoing transcatheter aortic valve replacement (TAVR) Methods: A propensity‐score matched analysis including 267 patients who underwent TAVR between 2009 and 2023. Information on pre‐, intra‐, and postoperative variables was collected. The main outcomes were survival and freedom from readmission for heart failure on long term follow‐up comparing the group with significant MR (sMR) (moderate–severe) vs. the control group. Results: The prevalence of sMR was 22%. TAVR improved the severity of MR in 65% of the patients. There were no significant differences on the main early postoperative outcomes. sMR was not associated with a lower survival on long‐term follow‐up but readmission for heart failure was higher in this group. Conclusions: MR is highly prevalent in patients undergoing TAVR. The procedure has a beneficial effect on the severity of concomitant MR. sMR was not associated with a higher mortality in long‐term follow‐up, patients with sMR experience a significant improvement in symptoms after TAVR although sMR was associated with higher heart failure readmissions.Keywords
This publication has 26 references indexed in Scilit:
- Natural History of Mitral Regurgitation After Transcatheter Aortic Valve ImplantationThe Annals of Thoracic Surgery, 2024
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Revista Española de Cardiología (English Edition), 2022
- Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve‐in‐Valve RegistryCatheterization and Cardiovascular Interventions, 2020
- Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVRJACC: Cardiovascular Interventions, 2020
- Mitral valve regurgitation in patients undergoing TAVI: Impact of severity and etiology on clinical outcomeInternational Journal of Cardiology, 2020
- La insuficiencia tricúspide, y no la insuficiencia mitral, determina la mortalidad en pacientes que presentan insuficiencia mitral no grave previa a TAVIRevista Española de Cardiología (English Edition), 2018
- Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve ReplacementThe American Journal of Cardiology, 2016
- Mitral regurgitation prior to transcatheter aortic valve implantation influences survival but not symptomsInternational Journal of Cardiology, 2016
- Meta-Analysis of the Impact of Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2015
- Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic StenosisThe American Journal of Cardiology, 2014